Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a US$7.2 billion cash-and-stock deal which will bolster its neuroscience business with the addition of a cannabis-based epilepsy treatment.
Jazz Pharma to buy GW Pharma for US$7.2 bln, adding cannabis-based drug to portfolio
